VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases ...
Reported and adjusted* EPS were $11.18 and $11.13 for full-year 2025, compared with $9.71 and $10.65 for full-year 2024Cash from operations was $944 ...
Revenue1 decreased 3% from prior year to $2.9 billion for the quarter and decreased 2% to $9.7 billion for the year due to ...
Explore why traditional working capital concepts don't apply to banks and understand alternative financial metrics that ...
Very strong Q4 2025 at +5.9% Confident in delivering a 7th year of outperformance in 2026 February 3, 2026 +5.9% Q4 organic growth, leading to +5.6% in 2025Solid FY performance across all regions: U.S ...
In March 2025, Publicis Groupe announced the acquisition of Lotame, the leading independent identity solution. The combined ...
Analysts said higher sales, lower costs, easing finance expenses, efficient working capital management, stable demand, steady exchange rates, and operational efficiency drove the improved performance ...
B.C. is seeing a shortage of long-term care beds even as a “silver tsunami” of aging baby boomers threatens to overwhelm an already strained system with monthslong waits.
Reported earnings of $2.8 billion; adjusted earnings of $3.0 billion Cash flow from operations of $10.8 billion; adjusted free cash flow of $4.2 billion Increased 2025 worldwide and U.S. production by ...
Quarterly net income of $492 million and quarterly net income excluding identified items1 of $968 million Cash flows from operating activities of $1,918 million Quarterly Upstream production of ...
These include global or regional changes or imbalances in the supply and demand for oil, natural gas, petrochemicals, and feedstocks and other market factors, economic conditions and seasonal ...
On track to deliver on 2027 ambitionsFourth quarter summary - – Revenue amounted to SEK 21.3 billion (21.4) and increased 1.6 ...